10x Genomics excels in single-cell and spatial ... The firm's GEM-X technology aims to reduce the cost of this work for researchers, and make these more scalable as our understanding of these ...

The market expects 10x Genomics (TXG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

"The entire department that I work with consist of very intelligent individuals that are great at their job. The best part is that every person in my department is kind and willing to teach me and ...

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) today Published first on TheFly – the ultimate source for ...

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...

Jan. 2, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq ... but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

Our facility is equipped with state-of-art instruments, including the 10X Genomics Chromium X which enables high-throughput single cell gene expression profiling, 10X Genomics Xenium platform, and the ...